Author

M. Janecek

University of CambridgeORCID 0000-0003-0740-641XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

M. Janecek3 papers

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:C. elegans· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alfonso De SimoneiD· 1 shared Chetan PoudeliD· 1 shared Claire H. Michel· 1 shared Clemens F. KaminskiiD· 1 shared David R. SpringiD· 1 shared Fabrice GieleniD· 1 shared Florian HollfelderiD· 1 shared Gabriele S. Kaminski SchierleiD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alfonso De SimoneORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A unified in vitro to in vivo fluorescence lifetime screening platform yields amyloid β aggregation inhibitors

Súil Collins, Liisa van Vliet, Fabrice Gielen, M. Janecek, Sara Wagner-Valladolid, Chetan Poudel, Giuliana Fusco, Alfonso De Simone, Claire H. Michel, Clemens F. Kaminski, David R. Spring, Florian Hollfelder, Gabriele S. Kaminski Schierle

The paper develops a unified in vitro to in vivo fluorescence lifetime screening platform to identify amyloid β aggregation inhibitors, revealing a new compound effective in multiple models.

bioRxiv · Mar 28, 2022 · PreprintMolecular Biology